This is another type of insulin used to manage blood sugar. It's designed to last longer in the body, helping keep blood sugar levels steady between meals.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Insulin detemir, sold under the brand name Levemir, is a long-acting insulin used to improve blood sugar control in adults and children with diabetes. In type 1 diabetes, where the body makes little or no insulin, it supplies the steady background insulin the body needs around the clock. In type 2 diabetes, it is often added when tablets or other non-insulin medicines no longer keep blood sugar in range. It is not a treatment for diabetic ketoacidosis (DKA), a dangerous buildup of acids in the blood that needs fast-acting insulin in a hospital. Novo Nordisk stopped selling Levemir in the United States at the end of 2024. People who were using it have generally moved to another long-acting insulin, such as insulin glargine (Lantus and similar products) or insulin degludec (Tresiba). If you still have Levemir or are being switched from it, your care team will set the new dose, because long-acting insulins do not all behave identically.
Insulin is the hormone that lets muscle and fat cells take sugar out of the blood and tells the liver to stop releasing more. Even between meals and overnight, the body needs a low, steady level of insulin to keep the liver's sugar output in check. This is called basal, or background, insulin. Insulin detemir is a modified version of human insulin built to last. After injection, its molecules cling to each other under the skin and are absorbed slowly, and once in the blood they attach to albumin, a common blood protein, which slows their delivery to tissues further. The result is a fairly even effect without a sharp peak. How long a dose lasts varies from person to person, from well under a day to about 24 hours, which is why some people take it once a day and others need two doses. It does not cover the rise in blood sugar after a meal, which is the job of a separate mealtime insulin or other diabetes medicines.
Insulin detemir is injected under the skin of the thigh, upper arm or abdomen with a prefilled pen or a syringe from a vial. Once-daily doses are usually taken with the evening meal or at bedtime; when taken twice a day, the second dose comes with the evening meal, at bedtime or about 12 hours after the morning dose. The dose is set individually and adjusted over time based on blood sugar readings, so it is normal for it to change, especially at first. In type 1 diabetes, it is always used together with a rapid-acting or short-acting mealtime insulin; on its own it cannot replace everything the body is missing. It should not be mixed in the same syringe with any other insulin, diluted, used in an insulin pump or given into a vein. Moving to a new spot within the same area each time helps prevent lumpy or thinned skin, and injecting into those areas can make the insulin absorb unpredictably. Pens, needles and syringes should never be shared, even with a fresh needle, because sharing can spread blood-borne infections.
Low blood sugar (hypoglycemia) is the most common side effect and the one that matters most. For many people with diabetes, low means a reading below 70 mg/dL, though your team may give you a different number. Shakiness, sweating, anxiety, irritability, confusion, dizziness and hunger are typical warning signs. The usual response is to take 15 to 20 grams of fast sugar, such as four glucose tablets or half a cup of regular juice, then recheck after 15 minutes and repeat if still low. Lows are more likely after missed meals, extra exercise, alcohol or a dose change, and they can make driving unsafe. Severe hypoglycemia, when someone is too confused or drowsy to treat themselves, passes out or has a seizure, is an emergency. Someone nearby should give glucagon, a rescue medicine given as a nasal spray or injection, if it is available, and call 911 right away. People who have had diabetes for many years or who have frequent lows may not feel the usual warning signs, which makes regular glucose checks or a continuous glucose monitor more important. Other effects include redness, itching or swelling where the insulin is injected, modest weight gain and some ankle swelling. Rarely, insulin causes a serious whole-body allergic reaction; widespread hives, swelling of the face or throat or trouble breathing need emergency care.
Many medicines change how much insulin a person needs. Other diabetes medicines, including semaglutide and similar medicines that mimic the gut hormone GLP-1 (glucagon-like peptide-1), can add to the risk of lows, so the insulin dose is often lowered when they are started. Steroids such as prednisone, some antipsychotics and certain hormones can push blood sugar up. Beta-blockers, a common class of heart and blood pressure medicines, can hide the shaking and racing heartbeat that usually signal a low. Alcohol can cause delayed lows. Tell the prescriber and pharmacist about any new prescription or supplement so the dose and monitoring can be adjusted. Pioglitazone (Actos), a diabetes tablet in the thiazolidinedione group, can cause fluid retention when combined with insulin, which may lead to or worsen heart failure; new shortness of breath, rapid weight gain or leg swelling should be reported. Insulin should not be injected while blood sugar is already low, and it should not be used by anyone who has had a serious allergic reaction to insulin detemir. Mix-ups between insulin types are a known source of dangerous lows, so check the label before every injection, especially if you also use a mealtime insulin. Pregnancy studies have not shown that insulin detemir harms a developing baby, while poorly controlled blood sugar does carry real risks, so anyone pregnant or planning pregnancy should review their insulin plan with their team.
Starting basal insulin is usually a gradual process. The first dose is often conservative, and the prescriber raises it over days to weeks according to fasting blood sugar readings, so frequent finger-stick checks or a continuous glucose monitor are part of the early routine. Improvement in hemoglobin A1C, a blood test that reflects average blood sugar over about three months, shows up at follow-up visits after that. For most people insulin is a long-term treatment rather than a short course. Doses often need adjusting during illness, with changes in activity or eating patterns, and as kidney or liver function changes. When control improves quickly, some people briefly notice blurry vision; people with existing diabetic eye disease should keep up with eye exams. Because Levemir is no longer sold in the United States, the practical next step for most current users is a planned switch to another basal insulin, with closer blood sugar checks for the first weeks after the change.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Levemir (Insulin Detemir), what you've noticed, or ask the community a question.